The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Microglial priming of antigen presentation and adaptive stimulation in Alzheimer’s disease
Open accessAbstract
The prominent pathological consequences of Alzheimer's disease (AD) are the misfolding and mis-sorting of two cellular proteins, amyloid-β and microtubule-associated protein Tau. The accumulation of toxic phosphorylated Tau inside the neurons induces the increased processing of amyloid-β-associated signaling cascade and vice versa. Neuroinflammation-driven synaptic depletion and cognitive decline are substantiated by the cross talk of activated microglia and astroglia, leading to neuron degeneration. Microglia are the brain-resident immune effectors that prove their diverse functions in maintaining CNS homeostasis via collaboration with astrocytes and T lymphocytes. Age-related senescence and chronic inflammation activate microglia with increased pro-inflammatory markers, oxidative damage and phagocytosis. But the improper processing of misfolded protein via lysosomal pathway destines the spreading of 'seed' constituents to the nearby healthy neurons. Primed microglia process and present self-antigen such as amyloid-β and modified Tau to the infiltrated T lymphocytes through MHC I/II molecules. After an effective conversation with CD4 + T cells, microglial phenotype can be altered from pro-active M1 to neuro-protective M2 type, which corresponds to the tissue remodeling and homeostasis. In this review, we are focusing on the change in functionality of microglia from innate to adaptive immune response in the context of neuroprotection, which may help in the search of novel imm…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The recent finding therefore suggests that at least some plaque-associated microglia may borrow elements of lymphoid signaling logic rather than merely presenting antigen to lymphocytes [44,45,46].”
From Lymphoid-like Suppressive Microglia in Alzheimer’s Disease: A New Neuroimmune Regulatory Axis? (2026) · cites this paper as [44]
In the citing paper
“Reviews of microglia–lymphocyte communication have emphasized that microglia may act as local regulators of lymphocyte activation, particularly when blood–brain barrier dysfunction or chronic neuroinflammation allows greater immune-cell trafficking into the CNS.”
From Lymphoid-like Suppressive Microglia in Alzheimer’s Disease: A New Neuroimmune Regulatory Axis? (2026) · cites this paper as [44]
In the citing paper
“In inflammatory and neurodegenerative settings, microglia can upregulate antigen-presentation machinery, respond to interferon-γ and other lymphocyte-derived cytokines, and influence T-cell behavior within or near the central nervous system.”
From Lymphoid-like Suppressive Microglia in Alzheimer’s Disease: A New Neuroimmune Regulatory Axis? (2026) · cites this paper as [44]
In the citing paper
“They can express molecules associated with antigen presentation, including MHC class II–related genes and co-stimulatory ligands such as CD80 or CD86, especially under inflammatory conditions.”
From Lymphoid-like Suppressive Microglia in Alzheimer’s Disease: A New Neuroimmune Regulatory Axis? (2026) · cites this paper as [44]
Citations
Cites
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Host microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547
Advanced glycation end-products: A review
Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
Tang, Y., & Le, W. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9070-5 · Cited by 2,190
Elmore, M. R. P., Najafi, A. R., Koike, M. A., Dagher, N. N., Spangenberg, E. E., Rice, R. A., Kitazawa, M., Matusow, B., Nguyen, H., West, B. L., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.040 · Cited by 1,968
Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms
Rőszer, T. (2015) · Mediators of Inflammation · doi:10.1155/2015/816460 · Cited by 1,762
Cited by
Sorted by citations
Items 101–145 of 145
Actin-associated growth cone of Tau and its intracellular localization
Velmurugan, G., Chandrashekar, M., & Chinnathambi, S. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.025 · Cited by 1
Self-citationiPSC-derived neurospheres: A cellular platform for Tau and Alzheimer’s disease immunotherapy
Chinnathambi, S., Adityan, A., Chandrashekar, M., & Velmurugan, G. (2025) · Advances in immunology · doi:10.1016/bs.ai.2025.11.001 · Cited by 1
Self-citationInteracting partners of Tau protein in Alzheimer’s disease
Chinnathambi, S., Velmurugan, G., Kumarappan, M., & Chandrashekar, M. (2025) · Advances in clinical chemistry · doi:10.1016/bs.acc.2025.10.005 · Cited by 1
Self-citationYou are what you degrade: tracking the cellular fates of the proteasomal degradome
Dantis, D. S., & Trader, D. J. (2026) · Molecular Omics · doi:10.1093/momics/aaiaf002 · Cited by 1
Tau and amyloid-β imaging with proteomics and genomics
Chinnathambi, S., Baisya, U., & Ananthanarayana, V. (2026) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2026.02.009 · Cited by 1
Self-citationAdvances in the treatment of Alzheimer’s disease
Goceroglu, R. T., & Hacımüftüoğlu, A. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1819165 · Cited by 1
Apolipoprotein E and Tau interaction in Alzheimer's disease
Chinnathambi, S., Adityan, A., Chidambaram, H., & Chandrashekar, M. (2024) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2024.10.003 · Cited by 1
Self-citationα- Linolenic Acid Modulates Phagocytosis of Extracellular Tau and Induces Microglial MigrationPreprint
Desale, S. E., & Chinnathambi, S. (2020) · doi:10.21203/rs.3.rs-30891/v1 · Cited by 1
Self-citationLymphoid-like Suppressive Microglia in Alzheimer’s Disease: A New Neuroimmune Regulatory Axis?
Chmiel, J., Gawełczyk, W., Soczyńska, J., & Leszek, J. (2026) · Cells · doi:10.3390/cells15131151
“In this framework, molecules such as MHC-II, CD80, CD86, CD40, and related co-stimulatory or co-inhibitory pathways become relevant because they determine whether immune recognition leads to activation, restraint, or tolerance [44,45].”
Scassellati, C., & Bonvicini, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819641-0.00103-1
Wang, J., Lei, Y., Zhu, F., Yu, J., Huo, X., Yang, C., Zhao, P., Huang, Y., Hao, M., Liu, Y., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3713044/v1
Stasiak, K., Stevens, A. D., Bolte, A. C., Curley, C. T., Lanfranca, M. P., Lindsay, R. S., Eyo, U. B., Lukens, J. R., Price, R. J., Bullock, T. N. J., et al. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03832-0
Formaldehyde, Neuroinflammation, and Cognitive Impairment
Kang, N., Liu, Y., & He, R. (2025) · Springer eBooks · doi:10.1007/978-981-96-7281-3_12
Chinnathambi, S., Dubey, T., & Rangappa, N. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.08.009
Self-citationAntimicrobial peptides inhibit Tau aggregation and modulates its pathology
Chinnathambi, S., Rangappa, N., & Malik, S. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.09.002
Self-citationAntimicrobial peptides act as a component of brain immunity against microbes in Alzheimer’s disease
Chandrashekar, M., Velmurugan, G., Mishra, A., & Chinnathambi, S. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.016
Self-citationSignaling cascades of microtubule-associated protein Tau in Alzheimer’s disease
Velmurugan, G., Krishnan, D., Upadhyay, R., Sivasamy, R., Sevanan, M., & Chinnathambi, S. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.013
Self-citationRommy von Bernhardi, M., Cortes, F., Narea, C., Metz, C., Godoy, G., & Eugenín, J. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311378
Chinnathambi, S., Rangappa, N., & Chandrashekar, M. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.023
Self-citationCytoskeltal intermediate filaments in Tau pathology and neurodegeneration
Chinnathambi, S., & Malik, S. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.028
Self-citationChinnathambi, S., Suresh, S., Velmurugan, G., & Mishra, A. (2025) · Advances in immunology · doi:10.1016/bs.ai.2025.11.004
Self-citationAnanathanarayana, V., Upadhyay, R., Illanad, G. H., Krishnan, D., Bochageri, N. P., Sevanan, M., Bagewadi, Z., Sivasamy, R., & Chinnathambi, S. (2025) · Advances in immunology · doi:10.1016/bs.ai.2025.11.002
Self-citationWang, M., Feng, L.-R., Li, Z.-L., Ma, K.-G., Chang, K.-W., Chen, X., Pengbo, Y., Ji, S.-F., Ma, Y.-B., Han, H., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14870648
Wang, M., Feng, L.-R., Li, Z.-L., Ma, K.-G., Chang, K.-W., Chen, X., Pengbo, Y., Ji, S.-F., Ma, Y.-B., Han, H., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14870642
Chinnathambi, S., & Das, R. (2024) · Figshare · doi:10.6084/m9.figshare.26591393
Self-citationInduced-pluripotent stem cell-derived immunotherapy for Tau and Alzheimer’s disease
Chinnathambi, S. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.005
Self-citationTherapeutics immunotargets for Tauopathy
Chinnathambi, S., & Rangappa, N. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.015
Self-citationPodosomes in Alzheimer’s disease
Malik, S., Velmurugan, G., Mishra, A. K., & Chinnathambi, S. (2026) · Advances in pharmacology · doi:10.1016/bs.apha.2025.12.002
Self-citationÉtude de la composante neuroinflammatoire dans les DFT/SLA
Smeyers, J. (2020) · theses.fr (ABES) · doi:10.70675/219cfa6fz5b3az4198z9deczdfaad3cd784c
Xiao, K. (2025) · International Conference on Computational Biology and Bioinformatics (ICCBB) · doi:10.1145/3789938.3789980
Cellular clearance mechanisms in neurodegenerative diseases
Velmurugan, G., Mishra, A., & Chinnathambi, S. (2026) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2026.06.004
Self-citationChinnathambi, S., & Desale, S. E. (2026) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2026.05.033
Self-citationAmyloid beta and Tau: Innate antimicrobial peptide target in Alzheimer’s diseases
Chandrashekar, M., Velmurugan, G., Rangappa, N., & Chinnathambi, S. (2026) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2026.06.008
Self-citationSmall molecular chaperones regulate protein quality control in neurodegenerative diseases
Rangappa, N., Mishra, A., & Chinnathambi, S. (2026) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2026.06.006
Self-citationAutophagy and molecular chaperones in neurodegenerative disease
Upadhyay, R., Rangappa, N., Sevanan, M., & Chinnathambi, S. (2026) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2026.06.003
Self-citationWang, C., Yun, Q. I., Zhang, Z., Zhao, H., Lin, F., & Cao, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1877167
Tau-mediated Mechanisms in Alzheimerʼs Disease Pathogenesis
Narayanappa, T. S., Ananthanarayana, V., & Chinnathambi, S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06057-7
Self-citationCX3CR1-mediated extracellular Tau internalization and phagosomal proteins in iPSC-derived microglia
Narayanappa, T. S., Ananthanarayana, V., & Chinnathambi, S. (2026) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2026.07.011
Self-citationNarayanappa, T. S., & Chinnathambi, S. (2026) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2026.07.022
Self-citationMicroglial regulation of extracellular Tau dynamics in Alzheimer’s disease
Narayanappa, T. S., & Chinnathambi, S. (2026) · Advances in pharmacology · doi:10.1016/bs.apha.2026.08.006
Self-citationZheng, Y., Cheng, J., Li, F., Ren, Z., Chen, C., Zhang, Z., Lan, X., Zhang, C., Zhao, Y., Han, J., et al. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04916-2
Endogenous versus exogeneous expression of Tau in iPSC-derived immune microglia
Ananthanarayana, V., Narayanappa, T. S., & Chinnathambi, S. (2026) · Advances in pharmacology · doi:10.1016/bs.apha.2026.08.007
Self-citation
Metadata
- Authors
- Das, R., & Chinnathambi, S.
- Affiliations
- National Chemical Laboratory (IN)
- Corresponding author
- Chinnathambi, Subashchandrabose
- Venue
- Cellular and Molecular Life Sciences
- Published
- 2019-05-15
- Volume
- 76
- Issue
- 19
- Pages
- 3681-3694
- ISSN
- 1420-682X (ISSN-L)
- 1420-9071
- PMC
- PMC11105582
- OpenAlex
- W2945276138
- Cited by
- 147
- References
- 149
- Citations by year
- 2026: 18 · 2025: 28 · 2024: 24 · 2023: 22 · 2022: 8 · 2021: 29 · 2020: 16 · 2019: 1
- FWCI
- 1.40
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cellular and Molecular Life Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Department of Biotechnology , Ministry of Science and Technology (DBT-HDDB)- BT/PR/15780/MED/122/4/2016)
- Council of Scientific and Industrial Research (CSIR NCL MLP 029526)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- Alzheimer's disease, microglia, antigen presentation, neuroinflammation, amyloid-beta, tau protein, CD4+ T cells, M1/M2 microglial polarization, neuroprotection, astroglia, lysosomal processing, immunotherapy
- MeSH terms
- Alzheimer Disease, Brain, Humans, Immunotherapy, T-Lymphocytes, Neuroimmunomodulation, Protein Folding, Microglia, Antigen Presentation, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
